Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acthéane is a homeopathic medicine formulated as sublingual tablets, traditionally used for the relief of hot flashes and functional disorders associated with menopause. It is hormone-free and intended for perimenopausal and postmenopausal women seeking non-hormonal management of symptoms such as hot flashes, night sweats, sleep disturbances, and headaches. The product contains a combination of homeopathic dilutions of Actaea racemosa (black cohosh), Arnica montana, Glonoinum (nitroglycerin), Lachesis mutus (bushmaster snake venom), and Sanguinaria canadensis (bloodroot). Its mechanism of action is not established by conventional pharmacology; the efficacy relies on principles specific to homeopathy. Acthéane does not contain any hormones or phytoestrogens[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Actheane.